Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Exploring the role of T cell receptor signal strength on the effector function of chimeric antigen receptor T cells

FY 2021-22

Summary
The combination of two new immunotherapies, chimeric antigen receptor (CAR) T cell therapy and oncolytic virotherapy, shows promise for treatment of solid tumors. However, how to best combine these therapies to improve outcomes and therapeutic success still remains to be discovered. A treatment schedule of administering CAR T cells before oncolytic viruses (OVs) leads to the enrichment of CAR T cells with a virus-specific T cell receptor (TCR). Understanding the role of virus-specific TCRs and their associated signaling on CAR T cells can inform us how to best use OVs for therapeutic success. Specifically, this research aims to examine how the strength of the signal through the TCR affects the function and persistence of these CAR T cells. To answer this question, we will use a mouse model for a B cell lymphoma that will be administered with tumor-specific CAR T cells and a variety of OVs that differ by a single mutation. This single mutation in these OVs will mean they will not bind to the TCR on the CAR T cell with the same strength. By examining the phenotype and functional capabilities of these OV-specific CAR T cells we can learn about how these different signaling strengths affect the function of these CAR T cells. Knowing how TCR signal strength shapes T cell characteristics can allow us to modify OVs to best support CAR T cell therapy and improve the therapeutic effect of this combination therapy.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466691
Name
Savage Gillian M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of T cell receptor signal strength on the effector function of chimeric antigen receptor T cells
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chimeric Antigen Receptor T Cells; Combination Therapy; Immunotherapy; Oncolytic Viruses; T Cell Receptor Signaling; T Cell Signaling
Abstract
The combination of two new immunotherapies, chimeric antigen receptor (CAR) T cell therapy and oncolytic virotherapy, shows promise for treatment of solid tumors. However, how to best combine these therapies to improve outcomes and therapeutic success still remains to be discovered. A treatment schedule of administering CAR T cells before oncolytic viruses (OVs) leads to the enrichment of CAR T cells with a virus-specific T cell receptor (TCR). Understanding the role of virus-specific TCRs and their associated signaling on CAR T cells can inform us how to best use OVs for therapeutic success. Specifically, this research aims to examine how the strength of the signal through the TCR affects the function and persistence of these CAR T cells. To answer this question, we will use a mouse model for a B cell lymphoma that will be administered with tumor-specific CAR T cells and a variety of OVs that differ by a single mutation. This single mutation in these OVs will mean they will not bind to the TCR on the CAR T cell with the same strength. By examining the phenotype and functional capabilities of these OV-specific CAR T cells we can learn about how these different signaling strengths affect the function of these CAR T cells. Knowing how TCR signal strength shapes T cell characteristics can allow us to modify OVs to best support CAR T cell therapy and improve the therapeutic effect of this combination therapy.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Savage, Gillian M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~